Equity
TIMUCIN has made a profit without a break since 2019.
TIMUCIN has made a profit without a break since 2019.
The accounts state no turnover.
€13,385 of the debts are secured on the company's own assets.
In 2025, 34 people joined and 34 left.
Four of the last ten came late. The 2019 accounts came latest: 32 days after the end of the period.
Higher gross margin than 90% of companies in retail trade. Sector median €212,569 · 12,814 companies.
The dashed line is the sector median: 0.4% across 3,697 companies (NACE 47, small).
About 6 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, small). It does better than 31% of them on solvency, 21% on liquidity, 35% on profitability and 68% on growth.
The bankruptcy probability was computed on 09-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the low class on 30-06-2025, 0.8% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
In July 2024, 4,107 companies had the same profile as TIMUCIN has now. Each dot stands for 11 companies, two years later.
Another 0.2% stopped without a precise date, possibly only after those two years.
That fits the bankruptcy probability of TIMUCIN itself: 0.6% within 12 months.
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 4,107 companies, not a prediction for TIMUCIN. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Liquidity is tight, with a current ratio of 1.09 (0.99 in 2024), below the usual 1.5. Short-term debt is 72.9% and cash 9.2% of total assets. 82.8% of the assets are financed with debt and provisions.
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
The company filed its last 7 accounts on average 1 day before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
| Company | ||||
|---|---|---|---|---|
| TIMUCIN Antwerp | €2.0m | €0.9m | 17.2% | 17 |
| Slagerij Ceursters Oud-Turnhout | €2.3m | €0.9m | 13.6% | 13.4 |
| SLAGERIJ DIDIER Roeselare | €1.5m | €0.9m | 22.3% | 17.7 |
| BEVORA Aalter | €2.1m | €0.9m | 2.7% | 13.9 |
| ALVOKA Aalter | €2.0m | €1.0m | 8.9% | 16.4 |
| VIMERIS Aalter | €1.7m | €0.8m | 6.1% | 13.5 |
| KAREL & HERLINDE Willebroek | €2.0m | €0.9m | 62.6% | 15 |
These companies have the same main activity as TIMUCIN: retail sale of meat and meat products, excluding game and poultry (NACE 47221). They are comparable in size and age: total assets between €1.5m and €2.3m, founded between 2008 and 2018.
TIMUCIN files the abbreviated format. That format states no turnover. The gross margin rose from €73,395 in 2015 to €943,794 in 2025.
The balance sheet grew most from 2018 to 2020 through fixed assets.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
See how customers, suppliers and banks see your own company and what to improve first.
If something looks wrong or is missing, please tell us.